GGrantIndex
Sort

51,593 grants matching hepatitis

Project 1. Type 2 diabetes, APOC3 and cardiovascular disease

$633,102
Karin E. Bornfeldt · University Of Washington · P01 · FY2025 · HL

Recellularization of Liver Bioscaffolds

$632,993
Martin L Yarmush · Massachusetts General Hospital · R01 · FY2011 · DK

Making Better Decisions: Policy Modeling for AIDS and Drug Abuse

$632,906
Douglas K Owens · Stanford University · R01 · FY2017 · DA

Hepatic Rap1a in cholesterol homeostasis

$632,897
Lale Ozcan · Columbia University Health Sciences · R01 · FY2024 · HL

Collaborative Integration of HCV Molecular Virology and Mathematical Modeling

$632,809
Susan L Uprichard · Loyola University Chicago · R01 · FY2024 · AI

NK/DC Cross-Talk and Antiviral Response

$632,784
Luis J. Montaner · Wistar Institute · R01 · FY2008 · AI

Extracellular Vesicle-Based Digital Scoring Assay for Detecting Early-stage Hepatocellular Carcinoma

$632,772
Yazhen Zhu · University Of California Los Angeles · R01 · FY2023 · CA

Early Clinical Trials of New Anti-Cancer Agents with Phase I Emphasis

$632,747
Donald W. Kufe · Dana-Farber Cancer Inst · U01 · FY2009 · CA

Structure and Replication of Hepatitis Delta Virus

$632,726
John Marston Taylor · Research Inst Of Fox Chase Can Ctr · R01 · FY2008 · AI

Integration of Systems and Synthetic Biology to Advance Development of Human Tissues In Vitro

$632,676
Mo Reza Ebrahimkhani · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · DK

Next-Generation Sequencing Center for GHOSTing Hepatitis C Virus: Transforming Community Based Molecular Surveillance and Outbreak Investigation

$632,656
Todd M Allen · Massachusetts General Hospital · U24 · FY2020 · DA

Next-Generation Sequencing Center for GHOSTing Hepatitis C Virus: Transforming Community Based Molecular Surveillance and Outbreak Investigation

$632,656
Todd M Allen · Massachusetts General Hospital · U24 · FY2021 · DA

Next-Generation Sequencing Center for GHOSTing Hepatitis C Virus: Transforming Community Based Molecular Surveillance and Outbreak Investigation

$632,656
Todd M Allen · Massachusetts General Hospital · U24 · FY2019 · DA

Continuation of the Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN) Data Coordinating Center

$632,648
James A Tonascia · Johns Hopkins University · U24 · FY2019 · DK

A novel diagnostic biomarker for Hepatocellular Carcinoma(HCC)

$632,643
Xuanyong Lu · Imcare Biotech, Inc. · R44 · FY2015 · CA

HIV/STD Infection in an Urban High Risk Population

$632,573
National Development &Res Institutes · R01 · FY2005 · DA

HBV Capsid Effectors

$632,520
Raymond F. Schinazi · Emory University · R01 · FY2024 · AI

Insulin Regulation of Hepatic Function via Zone-Specific Transcriptional Programs

$632,478
Sudha B Biddinger · Boston Children'S Hospital · R01 · FY2021 · DK

Optimizing PrEP regimens for pregnant women in sub-Saharan Africa

$632,461
Benjamin H Chi · Univ Of North Carolina Chapel Hill · R01 · FY2023 · AI

The altered lipid and protein metabolism of pediatric patients with HIV infection

$632,408
Farook Jahoor · Baylor College Of Medicine · R01 · FY2007 · HD

Obesity, chemotherapy dosing, and breast cancer outcomes

$632,341
Elizabeth David Kantor · Sloan-Kettering Inst Can Research · R37 · FY2020 · CA

Quantitative ECT for Complex Imaging Tasks

$632,251
Stephen C Moore · Brigham And Women'S Hospital · R01 · FY2012 · EB

Leveraging HIV care infrastructure for implementation of context-adapted liver cancer comprehensive control strategies in Uganda: The LC3 Study

$632,241
Gregory D Kirk · Johns Hopkins University · U01 · FY2024 · CA

EVALUATING SUPERVISED HAART IN LATE STAGE HIV IN IDUS

$632,234
New York Academy Of Medicine · R01 · FY2000 · DA

Structure And Assembly Of The Hepatitis B Nucleocapsid Protein

$632,175
Paul T Wingfield · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2015 · AR